The combination of GSK343 and ATRA was effective in reducing PRAME-EZH2 complexes, while in contrast to a previous study in melanoma [18], we did not detect any significant differences in PRAME-RARα complexes upon single ATRA treatment. The gene discussed is EZH2; the disease is melanoma.